Company / SG&A per Share
Bausch & Lomb Corp SG&A per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$6.34
FY2025
5-year range
$3.97 / $6.34
FY2021-FY2025
Trend
+6.6%
vs FY2024
Sector context
#66 of 150
Health Care
What the data says
At $6.34, Bausch & Lomb Corp's sg&a per share ranks #85 of 150 in the Health Care sector. SG&A per Share has increased for 5 consecutive years, from $3.58 in FY2020 to $6.34 in FY2025.
Based on SEC 10-K filings.
6.34 in FY2025 with a 5-year CAGR of +12.1%.
Increased from $4.96 to $6.34 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +14.5%
- 5-Year CAGR
- +12.1%
- 10-Year CAGR
- -
Sector benchmark
#85 of 150 in Health CareTop 56% of 150This company $6.34 Sector average $11878.17
▼
-99.9% below sector average
Key checks
Key Insights
- Bausch & Lomb Corp's sg&a per share has grown for 5 consecutive years.
- In FY2025, sg&a per share increased 6.6% year-over-year.
- Ranks #66 out of 150 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.74 (distress zone, below 1.8 threshold)
- Negative profit margin: -6.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.34 | +6.6% |
| FY2024 | $5.95 | +19.9% |
| FY2023 | $4.96 | +17.5% |
| FY2022 | $4.22 | +6.4% |
| FY2021 | $3.97 | +10.9% |
| FY2020 | $3.58 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026